The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Amlodipine, Valsartan, Hydrochlorothiazide
amlodipine besylate valsartan hydrochlorothiazide · AMLODIPINE BESYLATE 10 mg/1; VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 · Tablet, Film Coated · Oral · Golden State Medical Supply, Inc.
NDC 51407-0670-30 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 64380-0199-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$5.83per unit
middle half $4.04–$7.20 · 3,193 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $5.83
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
58%of plans cover it
tier 1 · prior auth 0% · step therapy 0% · qty limit 78%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for amlodipine besylate valsartan hydrochlorothiazide (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Golden State Medical Supply Inc.United Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA201087
- TE code
- AB
- Approval date
- Jun 1, 2015
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of amlodipine besylate valsartan hydrochlorothiazide (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 5 mg/1; VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 5 mg/1; VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1; VALSARTAN 320 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 10 mg/1; VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1; VALSARTAN 320 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 10 mg/1; VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 5 mg/1; VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 5 mg/1; VALSARTAN 160 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 5 mg/1; VALSARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 160 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 10 mg/1; VALSARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 160 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 5 mg/1; VALSARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 160 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 5 mg/1; VALSARTAN 25 mg/1; HYDROCHLOROTHIAZIDE 160 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 10 mg/1; VALSARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 160 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 5 mg/1; VALSARTAN 12.5 mg/1; HYDROCHLOROTHIAZIDE 160 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Golden State Medical Supply, Inc. | AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 5 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
| Strides Pharma Science Limited | AMLODIPINE BESYLATE 10 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1; VALSARTAN 160 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Amlodipine, Valsartan, Hydrochlorothiazide — NDC 51407-0670-30," retrieved September 3, 2026, https://drugdashboards.com/drug/51407067030.
Free to cite with attribution — see how the data is put together.